Clinical trial
Safety and Efficacy Evaluation of Sugammadex in Cardiac Patients…
NCT00420680 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00420680 |
|---|---|
| Title | Safety and Efficacy Evaluation of Sugammadex in Cardiac Patients (19.4.309)(P05934) |
| Official title | A Multi -Center, Randomized, Parallel-Group, Placebo-Controlled, Safety Assessor-Blinded Trial, Evaluating the Safety and Efficacy of Sugammadex in Cardiac Patients |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anesthesia |
| Intervention type | Drug |
| Interventions | Sugammadex, Placebo |
| Enrollment | 120 |
| Start date | Nov 7, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jan 11, 2007 |
| Last update posted | Aug 22, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: